Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-019417)

Filing Details

Accession Number:: 0001209191-18-019417
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-13 18:56:44
Reporting Period:: 2018-03-09

Accepted Time:: 2018-03-13 18:56:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029142	Dynavax Technologies Corp	DVAX	Pharmaceutical Preparations (2834)	330728374

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1573072	F David Novack	C/O Dynavax Technologies 2929 Seventh Street, Suite 100 Berkeley CA 94710	Senior Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-03-09	450	$18.00	77,192	No	4	S	Direct
Common Stock	Disposition	2018-03-09	1,671	$17.96	75,521	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Includes 250 shares acquired under Issuer's 2004 Employee Stock Purchase Plan ("ESPP") on February 14, 2014, 250 shares acquired under Issuer's 2004 ESPP on August 14, 2014, 260 shares acquired under Issuer's 2014 ESPP on February 13, 2015, 300 shares acquired under Issuer's 2014 ESPP on August 14, 2015, 302 shares acquired under Issuer's 2014 ESPP on February 16, 2016 and 309 shares acquired under Issuer's 2014 ESPP on August 15, 2016.